Sunshine Biopharma Incorporated SBFM 深 沪
等待开盘 05-19 09:30:00 美东时间
0.6054
+0.321
+113.09%
华盛通- 最 高2.32
- 今 开1.85
- 成交量 21.87亿股
- 最 低 0.4114
- 昨 收 0.2841
- 总市值 303.06万
- 52周最高 2.43
- 市盈率 静 --
- 换手率 43690.34%
- 52周最低 0.2812
- 委 比 55.56%
- 总股本 500.59万
- 历史最高 19740.00
- 量 比 5263.58
- 振 幅 671.81%
- 历史最低 0.2812
- 每 手 1
- 风险率 0.25%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股夜盘 | Sunshine Biopharma Incorporated涨28.79%，最新股价0.37美元
Sunshine Biopharma Incorporated涨28.79%，报0.37美元
05-18 09:21
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Alpha Compute (NASDAQ:ALP) shares increased by 71.3% to $0.46 during T...
05-14 20:05
Why Nextpower Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
Nextpower Inc (NXT) shares rose in pre-market trading after reporting strong Q4 results, raising sales guidance, and announcing an acquisition.
05-13 17:59
美股夜盘 | 沃氪医疗涨66.67%，东方文化涨57.53%
System1 Inc涨-31.24%；Sunshine Biopharma Incorporated涨-19.20%；快辑半导体涨-16.27%
05-13 08:05
Sunshine Biopharma Stock Is Surging Thursday: Here's What's Happening
Shares of Sunshine Biopharma Inc. (NASDAQ: SBFM) are trading higher Thursday after the Florida-based pharmaceutical company announced the launch of a generic prescription drug.
2025-10-16 22:24
Sunshine Biopharma Canadian Subsidiary, Nora Pharma, Launches Pravastatin, Generic Prescription Drug In Therapeutic Class Of Lipid Metabolism Regulators
Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that its
2025-10-16 19:55
Sunshine Biopharma approves $5M strategic bitcoin investment
Sunshine Biopharma's (NASDAQ:SBFM) board has approved a $5M investment in Bitcoin as a strategic reserve asset. The investment aligns with the company’s broader strategy to enhance financial strength ...
2025-10-14 19:53
美股大行评级 | 最高186美元！戴尔科技或多家机构上调目标价； 高盛上调超微公司目标价至210美元
今日重点评级关注：富国银行：维持Kyverna Therapeutics"超配"评级，目标价从24美元升至27美元；Chardan Capital：维持Oculis Holding"买入"评级，目标价从33美元升至51美元
2025-10-09 10:51
Aegis Capital Reiterates Buy on Sunshine Biopharma, Maintains $7 Price Target
Aegis Capital analyst David Bouchey reiterates Sunshine Biopharma (NASDAQ:SBFM) with a Buy and maintains $7 price target.
2025-10-09 00:46
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Scinai Immunotherapeutics (NASDAQ:SCNI) stock rose 24.9% to $3.11 duri...
2025-07-02 20:06
